Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

From inhibition of radiographic progression to maintaining structural integrity: a methodological framework for radiographic progression in rheumatoid arthritis and psoriatic arthritis clinical trials.

Landewé R, Strand V, van der Heijde D.

Ann Rheum Dis. 2013 Jul;72(7):1113-7. doi: 10.1136/annrheumdis-2012-203159. Epub 2013 Apr 25.

PMID:
23619156
2.
3.

Visualisation of structural damage as a surrogate marker of radiographic progression in patients with rheumatoid arthritis.

Pfeil A, Oelzner P, Renz DM, Lehmann G, Wolf G, Boettcher J.

Ann Rheum Dis. 2014 Apr;73(4):e24. doi: 10.1136/annrheumdis-2013-204786. Epub 2013 Nov 11. No abstract available.

PMID:
24218405
4.
5.

Biomarkers of radiographic progression in psoriatic arthritis: a report from the GRAPPA 2011 annual meeting.

Fitzgerald O, Ritchlin CT, Mease PJ.

J Rheumatol. 2012 Nov;39(11):2189-92. doi: 10.3899/jrheum.120820.

PMID:
23118284
6.

Effect of tumour necrosis factor blockers on radiographic progression of psoriatic arthritis: a systematic review and meta-analysis of randomised controlled trials.

Goulabchand R, Mouterde G, Barnetche T, Lukas C, Morel J, Combe B.

Ann Rheum Dis. 2014 Feb;73(2):414-9. doi: 10.1136/annrheumdis-2012-202641. Epub 2013 Jan 25. Review.

PMID:
23355079
7.

Infliximab inhibits progression of radiographic damage in patients with active psoriatic arthritis through one year of treatment: Results from the induction and maintenance psoriatic arthritis clinical trial 2.

van der Heijde D, Kavanaugh A, Gladman DD, Antoni C, Krueger GG, Guzzo C, Zhou B, Dooley LT, de Vlam K, Geusens P, Birbara C, Halter D, Beutler A.

Arthritis Rheum. 2007 Aug;56(8):2698-707.

9.

[Inhibition of radiographic progression in rheumatoid arthritis by anti-rheumatic drugs (DMARDs)].

Suzuki Y, Wakabayashi T, Saito E, Suwa A.

Clin Calcium. 2007 Apr;17(4):546-52. Review. Japanese.

PMID:
17404484
10.

Is radiographic progression a realistic outcome measure in clinical trials with early inflammatory arthritis?

Landewé R, van de Heijde D.

Clin Exp Rheumatol. 2003 Sep-Oct;21(5 Suppl 31):S37-41. Review.

PMID:
14969048
11.

Efficacy and safety of adalimumab treatment in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis.

Poddubnyy D, Rudwaleit M.

Expert Opin Drug Saf. 2011 Jul;10(4):655-73. doi: 10.1517/14740338.2011.581661. Epub 2011 May 10. Review.

PMID:
21554150
12.
13.

Recent concepts in the inhibition of radiographic progression with biologics.

Keystone E.

Curr Opin Rheumatol. 2009 May;21(3):231-7. doi: 10.1097/BOR.0b013e328329f84f. Review.

PMID:
19365267
14.

Imaging of psoriatic arthritis.

Olivieri I, Scarano E, Padula A, D'Angelo S.

Reumatismo. 2007;59 Suppl 1:73-6.

15.

Tumour necrosis factor α blockers are more effective than methotrexate in the inhibition of radiographic joint damage progression among patients with psoriatic arthritis.

Eder L, Thavaneswaran A, Chandran V, Gladman DD.

Ann Rheum Dis. 2014 Jun;73(6):1007-11. doi: 10.1136/annrheumdis-2012-202959. Epub 2013 Apr 25.

PMID:
23619157
16.

Effects of glucocorticoids on radiological progression in rheumatoid arthritis.

Kirwan JR, Bijlsma JW, Boers M, Shea BJ.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD006356. Review.

PMID:
17253590
18.
19.

[The therapeutic benefits of systemic treatment of psoriatic arthritis? The example of golimumab in psoriatic arthritis].

Boulinguez S, Sibilia J.

Ann Dermatol Venereol. 2011 May;138(5 Suppl 1):H11-5. doi: 10.1016/S0151-9638(11)70067-9. French. No abstract available.

PMID:
21703459
20.

Is radiographic progression of late-onset rheumatoid arthritis different from young-onset rheumatoid arthritis? Results from the Swiss prospective observational cohort.

Mueller RB, Kaegi T, Finckh A, Haile SR, Schulze-Koops H, von Kempis J; SCQM physicians.

Rheumatology (Oxford). 2014 Apr;53(4):671-7. doi: 10.1093/rheumatology/ket399. Epub 2013 Dec 17.

PMID:
24352338

Supplemental Content

Support Center